financetom
Business
financetom
/
Business
/
Honeywell's Mixed Q3: EPS Beats, Misses On Sales, And Lowers FY24 Revenue Outlook
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Honeywell's Mixed Q3: EPS Beats, Misses On Sales, And Lowers FY24 Revenue Outlook
Nov 2, 2024 7:44 PM

Honeywell International Inc. ( HON ) shares are trading lower after the company reported third-quarter results and updated FY24 guidance.

Revenue grew 6% year-over-year (organic: +3%) to $9.728 billion, missing the consensus of $9.901 billion.

The sales increase was attributed to strong growth in defense and space, commercial aviation, and building solutions.

Adjusted EPS was $2.58 (+8% Y/Y), beating the consensus of $2.50.

Sales by Segments: Aerospace Technologies $3.912 billion (+12% Y/Y), Industrial Automation $2.50 billion (-5% Y/Y), Building Automation $1.75 billion (+14% Y/Y) and Energy and Sustainability Solutions $1.56 billion (+1% Y/Y).

Operating margin contracted by 180 bps Y/Y to 19.1%, and Segment margin remained flat Y/Y at 23.6% in the quarter.

Operating cash flow stood at $2.00 billion and, free cash flow was $1.72 billion. Honeywell ( HON ) held cash and equivalents of about $10.6 billion as of September 30, 2024.

The company deployed $3.1 billion to M&A, dividends, and capital expenditure.

FY24 Outlook: The company lowered sales guidance to $38.6 billion – $38.8 billion (from $39.1 billion – $39.7 billion prior) versus the consensus of $39.20 billion.

Honeywell ( HON ) tightened adjusted EPS guidance to $10.15 – $10.25 (from $10.05 – $10.25) versus the estimate of $10.13.

Also, Honeywell ( HON ) revised the outlook for segment margin to 23.4% – 23.5% (from 23.3% – 23.5% prior), with segment margin contraction of 10 bps to flat.

The company now expects an operating cash flow of $6.2 billion – $6.5 billion and a free cash flow of $5.1 billion – $5.4 billion.

Honeywell ( HON ) chairman and CEO Vimal Kapur said, “Our Accelerator operating system and culture of execution enabled us to grow segment profit by 6% in spite of transitory sales headwinds. We continue to see healthy order rates and sequential growth in our backlog, even excluding the impact of acquisitions closed in the quarter, giving us confidence in our ability to achieve our long-term targets.”

“We have made significant progress this year on the simplification and optimization of the Honeywell ( HON ) portfolio with the announcement of our plans to spin off Advanced Materials and exit our PPE business, as well as the closing of four strategic acquisitions.”

Investors can gain exposure to the stock via Themes Transatlantic Defense ETF ( NATO ) and Invesco Aerospace & Defense ETF ( PPA ) .

Price Action: HON shares are down 1.98% at $215.99 premarket at the last check Thursday.

Read Next:

Honeywell Expands Qualcomm Partnership: AI And Connectivity To Supercharge Energy Industry Operations

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Brookfield Asset Management Fund Buys US Student Housing Properties for $893 Million
Market Chatter: Brookfield Asset Management Fund Buys US Student Housing Properties for $893 Million
Dec 10, 2024
12:16 PM EST, 12/10/2024 (MT Newswires) -- A Brookfield Asset Management ( BAM ) property fund bought student housing properties in the US for $893 million, 36% lower than the cost of replacing the properties and a 19% discount to recent trades, Bloomberg reported Tuesday, citing a company spokesperson. The 14 properties, with a total of about 8,700 beds, serve...
Agilent Cancer Diagnostic Assay Receives Certification to Comply with New EU Regulations
Agilent Cancer Diagnostic Assay Receives Certification to Comply with New EU Regulations
Dec 10, 2024
12:10 PM EST, 12/10/2024 (MT Newswires) -- Agilent Technologies ( A ) Tuesday said European regulators have issued a class C in vitro diagnostic regulation certification for the company's PD-L1 IHC 28-8 pharmDx diagnostic assay. The companion diagnostic identifies the PD-L1 biomarker and the body's potential response to cancer therapies such as Bristol-Myers Squibb's (BMY) Opdivo that contain anti-PD-1 antibodies...
Trinseo Executes Transaction Support Agreement To Address Near-Term Debt Challenges
Trinseo Executes Transaction Support Agreement To Address Near-Term Debt Challenges
Dec 10, 2024
Trinseo PLC ( TSE ) shares are trading higher after the company announced it secured a transaction support agreement with key holders of its senior notes and term loans. As per the transaction support agreement, these creditors will support transactions aimed at refinancing near-term maturities, enhancing operating liquidity, extending the nearest debt maturity to 2028, and capturing a discount through...
Anaergia Expands Scope of Works Contract With Monterey One Water, in California
Anaergia Expands Scope of Works Contract With Monterey One Water, in California
Dec 10, 2024
12:11 PM EST, 12/10/2024 (MT Newswires) -- Anaergia ( ANRGF ) on Tuesday said it expanded the scope of its activities with Monterey One Water (M1W) in California to operate an organic waste co-digestion facility at M1W's Regional Treatment Plant. The company's Anaergia Technologies unit will manage the procurement of organic waste and operation of a new food waste receiving...
Copyright 2023-2026 - www.financetom.com All Rights Reserved